inovio pharmaceuticals stock

Business News, Editor's Choice, Market News, News, Stocks

INO Stock Up 4% Now, Inovio to Recruit All Coronavirus Vaccine Volunteers by End of April

By Darya Rudz Apr 24, 2020

Thanks to the progress in the vaccine development, Inovio (INO) stock has given a boost to investor confidence. Since the end of 2019, Inovio shares are 264,55% up. In the last month alone, the rise is 65%.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Rose 9.5% Yesterday, Up 4% in Pre-market as Vaccine Space Gets on Fire

By Steve Muchoki Apr 21, 2020

As of the market closed on Monday, shares of Inovio Pharmaceuticals (INO) were up by 9.6%, while Moderna (MRNA) rose 10.3%. Novavax (NVAX) blasted higher by 24.7%, and VBI Vaccines (VBIV) posted a comparable 24.2% gain.

Business News, Editor's Choice, Market News, News, Stocks

INO Stock Rose 4.69% on Friday, Inovio Partners with IVI and KNIH to Test COVID-19 Vaccine

By Darya Rudz Apr 20, 2020

Inovio Pharmaceuticals received $6.9 million to work with the International Vaccine Institute (IVI) and the Korea National Institute of Health (KNIH) and start Phase 1/2 clinical testing of its INO-4800 vaccine. Following the news, INO stock is up.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Down 4% on Monday, 1% Today, Can It Be Multimillionaire-maker Stock?

By Andy Watson Apr 14, 2020

Inovio Pharmaceuticals alongside Moderna are edging close to providing a vaccine for the novel coronavirus. However, Inovio (INO) stock is down these days.

Business News, Editor's Choice, Market News, News, Stocks

Bill Gates Leaves Microsoft Board of Directors, Focuses on COVID-19 Solution

By Teuta Franjkovic Mar 14, 2020

Bill Gates co-founded Microsoft in 1975 with Paul Allen and was CEO until 2000. Gates was director of the board at Microsoft until 2014. But now he is leaving the board to focus on philanthropy.

Business News, Indices, Market News, News, Stocks

Inovio (INO) Stock Plunges 28% in Pre-Market Results Today Following Disappointing Q4 Report

By Tolu Ajiboye Mar 13, 2020

Inovio stock has been swung significantly in the last 24 hours after rising on news of a new grant and plunging on news of its poor Q4 report.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Fell 42% on Tuesday after Its 30% Drop on Monday

By Teuta Franjkovic Mar 11, 2020

Citron Research warned investors that Ino stock would fall back to $2 and called for the Securities and Exchange Commission to investigate Inovio and suspend trading of its stock.

Editor's Choice, Market News, News, Stocks

Inovio (INO) Stock Crashes Over 30%, Citron Research Casts Doubt on Coronavirus Vaccine

By Tolu Ajiboye Mar 10, 2020

Inovio (INO) stock has now erased some of its YTD gains after Citron Research suggested the company was grandstanding. Citron’s analysts now put INO at $2.

Business News, Market News, News, Stocks

Oil Companies Stock Down as Dow Jones Plummets 1,800 Points, Biotech Stocks Also Bleeding

By Tolu Ajiboye Mar 9, 2020

Dow Jones has lost over 1,880 points due to a row of factors including Saudi’s oil price slash as well as the coronavirus that is quickly spreading. More bleeding is expected.

Business News, Editor's Choice, Market News, News, Stocks

Why Inovio Pharmaceuticals (INO) Stock Is Top Performer among Coronavirus Vaccine Stocks

By Tolu Ajiboye Mar 9, 2020

At the moment, Inovio (INO) is probably the best performing stock among the biotech companies, with over 300% gains. Let’s take a look at the reasons why this is so.

Business News, Market News, News, Stocks

Inovio (INO) Stock Rises 7.72%, 1 Million Coronavirus Vaccine Doses Expected by Year End

By Tolu Ajiboye Mar 5, 2020

Inovio(INO) stock is enjoying the rally as it put on almost 8% weight days after it announced that it will be speeding up plans for its coronavirus (COVID-19) vaccine.

Business News, Market News, News, Stocks

Inovio (INO) Stock Rises 69.70% as Human Trials of Coronavirus Vaccine Will Start in April

By Teuta Franjkovic Mar 4, 2020

Inovio plans to start a clinical trial of its coronavirus vaccine in the U.S. next month with the thought to expand to China and South Korea shortly thereafter.